Saturday 17 October 2026 Export AKBA’s income statement to Excel — free account

Akebia Therapeutics, Inc.

AKBA Healthcare Drug Manufacturers Specialty & Generic

Akebia Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $236.2 million, up 47.5% from fiscal 2024. In the quarter to June 2026, revenue fell 21.4%, EPS fell 3,433.3%, free cash flow fell 89.0% and total debt rose 5.31%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.67 0.03 −4.29%

Follow AKBA

Alert me

Market cap: $192.7M
P/E: 0.0×
Fwd P/E: −6.3×
Dividend yield: —
F-score: 7/9
Altman Z: −4.42
Beneish M: −3.16
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	361.06%	64.49%	(78.96%)	(109.38%)
Piotroski F-Score Full definition →		7	7	6	5
ROA Full definition →		(5.57%)	(1.79%)	(6.10%)	(8.53%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(12.58%)	(5.86%)	(29.07%)	(42.26%)
Average Days of Receivables Full definition →		107.39	72.68	98.22	89.15
Free Cash Flow per Share Full definition →		0.12	0.26	0.22	0.15
Free Cash Flow Full definition →		32.35	67.87	60.04	40.26
Capital Expenditures Full definition →		(0.05)	(0.12)	(0.33)	(1.29)
Other line items
Cash ROIC Full definition →		12.65%	25.54%	25.13%	17.50%
Accounts Receivable Turnover Full definition →		4.57	5.80	3.75	3.47
Accounts Payable Turnover Full definition →		4.01	2.17	4.19	4.26
Inventory Turnover Full definition →		2.42	2.48	2.70	3.00
Average Days of Payables Full definition →		77.85	195.95	69.37	77.05
Days of Inventory on Hand Full definition →		143.89	144.38	107.50	106.46
Tax Rate Full definition →		(0.21)	(0.38)	0.00	0.07
Research and Development Expense of Revenue Full definition →		21.10%	26.40%	29.01%	32.16%
Selling, General and Administrative Expense of Revenue Full definition →		48.46%	45.50%	48.27%	51.94%
Share Based Compensation of Revenue Full definition →		4.35%	4.78%	5.49%	6.08%
Interest Coverage Full definition →		0.68	0.97	0.25	(0.87)
Operating CF/Net income Full definition →		(2.04)	(12.72)	(2.94)	(1.40)
Depreciation/Fixed assets Full definition →		6.99	1.04	1.34	1.03
Capex/Depreciation Full definition →		0.00	(0.09)	(0.26)	(0.83)
Revenue per Share Full definition →		0.85	0.92	0.87	0.81
Operating CF per Share Full definition →		0.12	0.26	0.23	0.15
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.01

Show all line items

Columns are period end dates

Stockrow Weekly